Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Deborah DeRyckere
Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
mTORC1/autophagy-regulated MerTK in Mutant BRAFV600 Melanoma With Acquired Resistance to BRAF Inhibition
Oncotarget
Oncology
Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients
Clinical Cancer Research
Cancer Research
Oncology
Inhibitors of Pan-Pi3k Signaling Synergize With BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth
Frontiers in Oncology
Cancer Research
Oncology
Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma
Cancers
Cancer Research
Oncology
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
Frontiers in Oncology
Cancer Research
Oncology
Acquired Resistance to BRAF Inhibition in BRAFV600E Mutant Gliomas
Oncotarget
Oncology
Efficacy and Safety of BRAF Inhibition Alone Versus Combined BRAF and MEK Inhibition in Melanoma: A Meta-Analysis of Randomized Controlled Trials
Oncotarget
Oncology
Induction of Autophagy and Inhibition of Melanoma Growth in Vitro and in Vivo by Hyperactivation of Oncogenic BRAF
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Usp5 Links Suppression of P53 and FAS Levels in Melanoma to the BRAF Pathway
Oncotarget
Oncology